caffeine has been researched along with Central Nervous System Disease in 10 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "We tested the effect of caffeine, on hyperoxia-induced seizures." | 3.69 | Caffeine attenuates CNS oxygen toxicity in rats. ( Bitterman, N; Schaal, S, 1995) |
| " Differences among high, moderate and low users were common, and some dose-response associations were apparent." | 1.26 | Somatic manifestations of caffeinism. ( Greden, JF; Lubetsky, M; Victor, BS, 1981) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 3 (30.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Łukawski, K | 1 |
| Raszewski, G | 1 |
| Kruszyński, K | 1 |
| Czuczwar, SJ | 1 |
| Zaĭtseva, IN | 1 |
| Dall'Igna, OP | 1 |
| Porciúncula, LO | 1 |
| Souza, DO | 1 |
| Cunha, RA | 1 |
| Lara, DR | 1 |
| Dall'lgna, OP | 1 |
| Landry, GL | 1 |
| REID, G | 1 |
| George, SE | 1 |
| Ramalakshmi, K | 1 |
| Mohan Rao, LJ | 1 |
| Bernstein, E | 1 |
| Diskant, BM | 1 |
| Victor, BS | 1 |
| Lubetsky, M | 1 |
| Greden, JF | 1 |
| Bitterman, N | 1 |
| Schaal, S | 1 |
| Buletsa, BA | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Impact of Caffeine on Cognition in Schizophrenia[NCT02832401] | 24 participants (Actual) | Interventional | 2016-09-02 | Completed | |||
| Does Caffeine Enhance Bowel Recovery After Colorectal Surgery?[NCT03097900] | Phase 2 | 70 participants (Actual) | Interventional | 2017-11-02 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for caffeine and Central Nervous System Disease
| Article | Year |
|---|---|
Ephedrine use is risky business.
Topics: Caffeine; Cardiovascular Diseases; Central Nervous System Diseases; Central Nervous System Stimulant | 2003 |
9 other studies available for caffeine and Central Nervous System Disease
| Article | Year |
|---|---|
Neurological effects of acute exposure to caffeine and organophosphates in mice.
Topics: Animals; Caffeine; Central Nervous System Diseases; Chlorpyrifos; Cholinesterase Inhibitors; Dimetho | 2021 |
[Use of vasobral in therapy of central nervous system pathology in children of early age].
Topics: Administration, Oral; Caffeine; Central Nervous System Diseases; Child, Preschool; Dihydroergotoxine | 2010 |
Neuroprotection by caffeine and adenosine A2A receptor blockade of beta-amyloid neurotoxicity.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Caffein | 2003 |
[Cisternal therapy of encephalic and periencephalic diseases caused by central disorders; with a study on experimental psychiatry].
Topics: Caffeine; Central Nervous System Diseases; Humans; Procaine; Psychiatry | 1958 |
A perception on health benefits of coffee.
Topics: Caffeine; Calcium; Cardiovascular Diseases; Central Nervous System Diseases; Coffee; Health Status; | 2008 |
Phenylpropanolamine: a potentially hazardous drug.
Topics: Adolescent; Adult; Caffeine; Cardiovascular Diseases; Central Nervous System Diseases; Cerebral Hemo | 1982 |
Somatic manifestations of caffeinism.
Topics: Adult; Arrhythmias, Cardiac; Caffeine; Central Nervous System Diseases; Diarrhea; Diuresis; Dose-Res | 1981 |
Caffeine attenuates CNS oxygen toxicity in rats.
Topics: Animals; Caffeine; Carbon Dioxide; Central Nervous System Diseases; Cerebrovascular Circulation; Dos | 1995 |
[On the facial reflexes of patients with diseases of the nervous system].
Topics: Antihypertensive Agents; Arachnoiditis; Brain Injuries; Caffeine; Central Nervous System Diseases; C | 1969 |